Vaginal Cream with Applicator

TERMINATED · PHASE4 · Recurrent Urinary Tract Infection, Vaginal Atrophy, Postmenopausal Disorder

High rates of loss to follow up

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.